Table 3

Occurrence of nSNVs in the TP53 3′UTR potentially affecting miRNA binding in DLBCL

SubgroupNo. of patients (%)
Training Set 76 of 244Validation Set 70 of 247Total 146 of 491
TP53 CDS status    
MUT-CDS 16 (21) NA NA 
WT-CDS 60 (79) NA NA 
3′UTR nSNV affecting putative miRNA binding* 
Generating only 12 17 
Disrupting only 31 23 54 
Generating and disrupting 15 24 
Others 18 33 51 
No. of 3′UTR nucleotides altered 
 1 42 (59.5) 42 (60) 84 (57.5) 
 2 19 (23.8) 18 (25.7) 37 (25.3) 
 3 8 (9.5) 7 (10) 15 (10.3) 
 4 5 (4.8) 3 (4.3) 8 (5.5) 
 5 1 (1.2) 1 (0.7) 
 6 1 (1.2) 1 (0.7) 
SubgroupNo. of patients (%)
Training Set 76 of 244Validation Set 70 of 247Total 146 of 491
TP53 CDS status    
MUT-CDS 16 (21) NA NA 
WT-CDS 60 (79) NA NA 
3′UTR nSNV affecting putative miRNA binding* 
Generating only 12 17 
Disrupting only 31 23 54 
Generating and disrupting 15 24 
Others 18 33 51 
No. of 3′UTR nucleotides altered 
 1 42 (59.5) 42 (60) 84 (57.5) 
 2 19 (23.8) 18 (25.7) 37 (25.3) 
 3 8 (9.5) 7 (10) 15 (10.3) 
 4 5 (4.8) 3 (4.3) 8 (5.5) 
 5 1 (1.2) 1 (0.7) 
 6 1 (1.2) 1 (0.7) 

Others, outside seed match or not in miRNA sites; NA, not applicable.

*

nSNVs predicted by TargetScan 5.0 to be targeted by miRNAs (based on the seed sequence of the miRNA plus A1 and m8). Some patients had both mutations generating miRNA binding and mutations disrupting it. Three SNPs listed in dbSNP that putatively affect miRNA binding (rs16956880 [205 G>A], rs11483 1472 [1070 G>A], and rs78378222 [1175 C>A]) were excluded.

Close Modal

or Create an Account

Close Modal
Close Modal